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Circadian rhythms, biological oscillations with a period of about 24 h, are maintained by an innate
genetically determined time-keeping system called the molecular circadian clockwork. Despite the
physiological and clinical importance of the circadian clock, development of small molecule modulators
targeting the core clock machinery has only recently been initiated. BMAL1, a core clock gene, is
controlled by a ROR/REV-ERB-response element (RORE)-dependent mechanism, which plays an impor-
tant role in stabilizing the period of the molecular circadian clock. Therefore, we aimed to identify a novel
small molecule modulator that regulates Bmal1 gene expression in RORE-dependency, thereby inﬂu-
encing the molecular feedback loop of the circadian clock. For this purpose, we carried out a cell-based
screen of more than 1000 drug-like compounds, using a luciferase reporter driven by the proximal region
of the mouse Bmal1 promoter. One compound, designated KK-S6, repressed the RORE-dependent
transcriptional activity of the mBmal1 promoter and reduced endogenous BMAL1 protein expression.
More importantly, KK-S6 signiﬁcantly altered the amplitude of circadian oscillations of Bmal1 and Per2
promoter activities in a dose-dependent manner, but barely affected the period length. KK-S6 effectively
decreased mRNA expression of metabolic genes acting downstream of REV-ERBa, Pai-1 and Citrate
synthase, that contain RORE cis-element in their promoter. KK-S6 likely acts in a RORE-dependent
manner by reinforcing the REV-ERBa activity, though not by the same mechanism as known REV-ERB
agonists. In conclusion, the present study demonstrates that KK-S6 functions as a novel modulator of
the amplitude of molecular circadian rhythms by inﬂuencing RORE-mediated BMAL1 expression.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).otein 1; CLOCK, circadian lo-
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Inc. This is an open access article u1. Introduction
Most biological processes in mammals have circadian rhythms
with periods of about 24 h. The circadian timing system is orga-
nized hierarchically into multiple oscillator networks. Coordination
of the circadian system across the body involves regulation of sig-
nals emanating from the suprachiasmatic nuclei (SCN), a central,
master pacemaker in the anterior hypothalamus, and subsidiary
clocks in the extra-SCN brain regions and peripheral organs, which
regulate physiological and behavioral outputs [1,2].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cells, and consists of two interlocked positive/negative feedback
loops. In the core clock loop, CLOCK and BMAL1 form heterodimers
that positively regulate the transcription of Periods (Per1, Per2, and
Per3) and Cryptochromes (Cry1 and Cry2) genes by activating a cis-
element, the E-box, in the promoters of these genes. PERs and CRYs
are phosphorylated by casein kinases and can dimerize [3]. This
complex translocates into the nucleus where it negatively regulates
the transcriptional activity of the CLOCK:BMAL1 heterodimer. In
addition, the circadian nuclear receptors, RORs and REV-ERBs,
compete for binding of the RORE in the Bmal1 promoter region;
REV-ERBs suppress Bmal1 transcription, whereas ROR induces it,
forming a stabilizing loop [4]. In addition to the transcriptional
regulation underlying the molecular makeup of the clock machin-
ery, the post-translational modiﬁcation processes, including the
phosphorylation [5], ubiquitination, sumoylation [6], signal trans-
duction [7], and subcellular trafﬁcking [8] of the clock proteins have
been extensively studied.
Extensive studies on the phenotypes of mutant mice with
defective clock genes, as well as pathophysiological consequences
of circadian disruption, have highlighted the therapeutic potential
of circadian molecular clockwork for treating a wide range of
human diseases such as metabolic disorders, cardiovascular dis-
eases, immune system dysfunction, neuropsychiatric disorders,
and even cancers. Both endogenous and synthetic small molecules
have recently been identiﬁed as circadian clock modulators. For
example, heme [9], cAMP [10], and NAD [11] have been shown to
affect the periodicity of the molecular circadian clock. Casein ki-
nase I inhibitors such as longdaysin [12] and LH846 [13] were also
shown to change the circadian period. More recently, small mol-
ecules directly targeting core clock components have been
developed; synthetic ligands of REV-ERBs, including GSK4112,
SR8278, SR9009, and SR9011 [14e16] were developed as prom-
ising molecular clock modulators. Small molecules stabilizing
CRYs, such as KL001 and its derivatives, suppress the transcrip-
tional activity of the CLOCK:BMAL1 heterodimer by strengthening
the negative feedback inhibition of CRYs, and are currently in pre-
clinical or clinical trials [17]. By screening our library of drug-like
chemical compounds, we recently identiﬁed KS-15, which can
directly bind to CRYs and impair their feedback of the CLOCK:-
BMAL1 heterodimer [18].
In the present study, we develop a novel modulator, KK-S6 that
selectively affects RORE-mediated transcriptional activity by cell-
based screening of our in-house chemical library. We also vali-
dated its functional signiﬁcance and REV-ERBa-dependency,
providing a novel mechanism in the control of circadian rhythms
through modulating the RORE-mediated activity by KK-S6.Table 1
Sequences of PCR primers used in the generation of mutated RORE reporter
Primer name Sequence
1 Primers for site-directed mutagenesis
RORE1 mutant F
R
RORE2 mutant F
R
2 Primers for RT-PCR
Bmal1 F
R
Pai-1 F
R
Citrate synthase F
R
Tbp F
R2. Materials and methods
2.1. Plasmid construction
The minimal mouse Bmal1 promoter was fused to the luciferase
reporter (wtBmal1::Luc) by inserting a 171-bp proximal fragment
of the mouse Bmal1 promoter containing two copies of RORE (106
to þ65 from the transcriptional start site) into the pGL3-promoter
vector (Promega) by use of the XhoI and NheI restriction sites.
Primer sequences are shown in Table 1. The RORE-mutated reporter
constructs (m1Bmal1::Luc, m2Bmal1::Luc, and m1/2Bmal1::Luc)
were generated by site-directed mutagenesis with the primers
(Table 1).
2.2. Cell culture
NIH3T3 and HepG2 cells were maintained in DMEM supple-
mented with 10% FBS and 1% penicillin/streptomycin (Invitrogen)
at 37 C under 5% CO2. NIH3T3 cells were transfectedwith thewild-
type or mutated reporter along with the pcDNA3.1 plasmid, and
stably transfected cells were established by selection in the pres-
ence of G418 (400 mg/ml) for 3 wks. Stably transfected cells were
then maintained in medium (DMEM supplemented with 10% FBS
and 2% penicillin/streptomycin) containing G-418 (100 mg/ml).
2.3. Measurement of luciferase reporter activity
For the conventional luciferase reporter assay, each indicated
luciferase reporter and expression construct was co-transfected
together with 400 ng of a Renilla luciferase reporter construct
(pRL-basic), as an internal control for transfection efﬁciency, into
NIH3T3 cells using Lipofectamine Plus reagent (Invitrogen). After
48 h, cell extracts were prepared by incubation in 0.1 mL of 1 lysis
buffer (Promega) for 20 min at room temperature. Fireﬂy and
Renilla luciferase activities were measured using the Dual Lucif-
erase Reporter Assay Kit (Promega). Reporter-driven ﬁreﬂy lucif-
erase activities were normalized relative to Renilla luciferase levels.
For real-time bioluminescence monitoring, stably transfected
cells were seeded in 35mm dishes. Cell cultures were synchronized
using 1 mMDEX for 2 h before and their mediumwas replaced with
fresh medium containing 0.1 mM D-luciferin (Promega) and either
vehicle (0.05% DMSO) or chemical compounds at the indicated
concentrations [18].
2.4. Cell-based screening of in-house chemical library
A small, druggable, scaffold-based library containing 1128constructs and ampliﬁcation of genes acting downstream of REV-ERBa.
5ʹ-CGG ATT GGT CGG AAA GTA CAT TAG TGG TGC GAC ATT TAG-3ʹ
5ʹ-CTA AAT GTC GCA CCA CTA ATG TAC TTT CCG ACC AAT CCG-3ʹ
5ʹ-GGA AGG CAG AAA GTA CAT CAG GGA CGG AGG C-3ʹ
5ʹ-GCC TCC GTC CCT GAT GTA CTT TCT GCC TTC C-3ʹ.
5ʹ-TTA AGA GGT GCC ACC AAT CC-3ʹ
5ʹ-TTC CCT CGG TCA CAT CCT AC-3ʹ
5ʹ-AAG ACT CCC TTC CCC GAC TC-3ʹ
5ʹ-GGG CGT GGT GAA CTC AGT ATA G-3ʹ
5ʹ-TAG TGC TTC CTC CAC GAA TTT Gʹ-3ʹ
5ʹ-CCA CCA TAC ATC ATG TCC ACA G-ʹ3ʹ
5ʹ-CGG CTG TTT AAC TTC GCT TC-3ʹ
5ʹ-TTC TTG GCA AAC CAG AAA CC-3ʹ
J. Lee et al. / Biochemical and Biophysical Research Communications 469 (2016) 580e586582compounds was described in our previous study [18]. Each com-
pound was dissolved in DMSO and used at the indicated dosage.
Compounds were screened by a cell-based assay using the
wtBmal1::Luc-transfected NIH3T3 cells in 24-well plates. Trans-
fected cells were treated with vehicle (0.05% DMSO) or chemical
compounds for 24 h.
2.5. RNA isolation and real-time quantitative PCR
RNA expression was analyzed according to our previous study
[19]. Total RNAwas isolated using the single-step acid guanidinium
thiocyanate-phenol-chloroform method. Real-time PCR was car-
ried out in the presence of SYBR Green I (Sigma). Gene expression
levels were normalized against expression of TATA box-binding
protein (Tbp). Primer sequences used for real-time RT-PCR are
shown in Table 1. The reactions were ﬁrst incubated at 94 C for
10 min, followed by 50 cycles at 95 C for 15 s, 62 C for 30 s, and
72 C for 30 s.
2.6. Western blot analysis
Whole-cell extracts were separated using 8% SDS-
polyacrylamide gels and transferred to polyvinylidene diﬂuoride
(PVDF) membranes (Millipore) in a Bio-Rad Trans-Blot electro-
phoresis apparatus using Towbin's buffer. The blots were blocked in
1  Tris-buffered saline containing 0.3% Tween-20 with 10%
skimmed milk, then incubated with primary antibody at room
temperature for 90 min. They were then washed four times withFig. 1. Validation of the luciferase reporter harboring the minimal Bmal1 promoter regi
(wtBmal1::Luc) or abrogated (m1Bmal1::Luc, m2Bmal1::Luc, and m1/2Bmal1::Luc) RORE.
ﬁbroblast cells measured using a real-time bioluminescence monitoring system. (C) Dose-de
expressed with ROR or REV-ERBa in NIH3T3 cells. (D) Comparison of changes in wild-type R
(n ¼ 6).1  TBS/0.3% Tween-20. Antibody binding was subsequently
detected by incubation with secondary antibodies linked to
horseradish peroxidase (Jackson Immuno Research Laboratories).
Expression levels were visualized using an ECL detection kit
(Pierce). Anti-BMAL1 and anti-a-actin (s.c.-56459; Santa Cruz)
were obtained commercially. Anti-BMAL1 antibody was raised by
immunization of rabbits and afﬁnity-puriﬁed, as described previ-
ously [20].
2.7. Statistical analysis
Data were statistically evaluated by Student's t-test or one-way
analysis of variance (ANOVA) with Tukey post-hoc tests using
GraphPad Prism software. P-values <0.05 were considered to be
signiﬁcant. All data shown are means ± SEM.
3. Results
3.1. Characterization of the wild-type and mutated luciferase
reporters
To identify novel circadian clock modulators affecting BMAL1
expression in an RORE-dependent manner, we prepared wild-type
and RORE-mutated luciferase reporter constructs (wtBmal1::Luc,
m1Bmal1::Luc, m2Bmal1::Luc, and m1/2Bmal1::Luc) based on the
171 bp proximal promoter region of themouse Bmal1 gene (Fig.1A).
The short Bmal1 promoter region, containing minimal promoter
elements and the essential RORE cis-element required for rhythmicon. (A) A schematic representation of the Bmal1::Luc reporter construct with wild-type
(B) Circadian oscillations on wild-type RORE or mutated RORE luciferase reporter in
pendent changes in the transcriptional activity of the wtBmal1::Luc reporter when co-
ORE and mutated RORE luciferase activity by ectopic expression of REV-ERBa or RORa.
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other enhancer elements. Cultured NIH3T3 cells transfected with
the wild-type reporter displayed a circadian oscillation when
induced by DEX, which requires intact RORE elements (Fig. 1B).
Transient expression of RORE-acting transcriptional regulators also
inﬂuenced the wtBmal1::Luc reporter activities in a RORE-
dependent manner: RORa induced reporter activity, whereas
REV-ERBa repressed it (Fig. 1C). On the contrary, a GG/CA mutation
in RORE1 and/or RORE2 completely abrogated the effects of REV-
ERBa or RORa on reporter activity and circadian oscillation proﬁles
(Fig. 1D).
3.2. Identiﬁcation of a synthetic compound modulating the RORE-
dependent Bmal1 transcription
In an initial attempt to identify circadian modulator(s), we
conducted a screen of 1128 previously described compounds [18] at
20 mM using wtBmal1::Luc-transfected cells (data not shown).
Intriguingly, a series of structurally-similar compounds was shown
to signiﬁcantly alter the reporter activity, and was designated the
KK-S series of compounds (Fig. S1). We then investigated the dos-
eeresponse relationships of selected compounds in the KK-S sub-
family (designated as KK-S1eS10) at concentrations ranging fromFig. 2. Identiﬁcation of KK-S6. (A) Dose-response curves showing the effects of the ten
scription. Luciferase levels of wtBmal1::Luc reporter were examined in the presence of in
DMSO). The grey dot indicates cellular damage by treatment with a high concentration of th
2Bmal1::Luc activities. **p < 0.01 compared to vehicle-treated group, yyp < 0.01 and yp <0.02 to 20 mM. All compounds except KK-S5 produced a dose-
dependent decrease in luciferase activity driven by the RORE
(Fig. 2A). When we compared the effects of the selected KK-S
compounds on the wild-type versus mutated Bmal1 promoter ac-
tivities, only KK-S6 resulted in a RORE-speciﬁc repression of lucif-
erase activity (Fig. 2B). KK-S6 consists of two aromatic systems
linked by an ethylene bridge. The R-group of KK-S6 contains a
unique alkyne (triple bond) unit, which can display a p-p interac-
tion as well as a hydrophobic interaction (Fig. 2C and S2).
3.3. Impact of KK-S6 on endogenous circadian clockwork
Next, we examined whether KK-S6 can inﬂuence the endoge-
nous circadian molecular clockwork. The effect of KK-S6 on
endogenous Bmal1 expressionwas assessed in comparisonwith the
effects exerted by known REV-ERBmodulators. Treatment with KK-
S6 signiﬁcantly reduced Bmal1 mRNA expression, to a similar
extent as heme, the endogenous ligand, or GSK4112, a synthetic
REV-ERB agonist (Fig. 3A). In accordance, KK-S6 and heme also
decreased BMAL1 protein levels, whereas treatment with lithium
increased BMAL1 protein expression (Fig. 3B). Lithium is known to
be an inhibitor of glycogen synthase kinase 3b (GSK3b), and
phosphorylation by GSK3b stabilizes REV-ERBs from degradationstructurally-related compounds, designated the KK-S series, on RORE-mediated tran-
dicated concentrations of a compound (7 concentrations of a 3-fold dilution series in
e compound. (B) Effects of selected KK-S compounds (5 mM) on wtBmal1:Luc and m1/
0.05 vs wtBmal1::Luc receiving the same treatment. (C) Structure of KK-S6.
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tivity driven by the mouse Bmal1 or Per2 promoter, to explore the
functional relevance of KK-S6 in the regulation of circadian mo-
lecular rhythms. Stable cell cultures harboring either wtBmal1::Luc
or Per2::Luc reporter were synchronized using 1 mM DEX for 2 h,
then bioluminescence signals were continuously monitored in the
absence or presence of KK-S6 at various concentrations. KK-S6
caused an apparent dose-dependent attenuation of the amplitude
of rhythmic activity levels of both reporter constructs, while it
barely affected the period length of the rhythm (Fig. 3C and D).
3.4. KK-S6 strengthens the transcriptional repression by REV-ERBa
We next assessed whether KK-S6 affected RORE-mediated
transcription by modulating the activity of REV-ERBs, which
belong to the nuclear receptor superfamily and are well known as
key transcriptional repressors of RORE-mediated downstream gene
expression [22]. Overexpression of Rev-erba to NIH3T3 cells
signiﬁcantly reduced wtBmal1::Luc reporter activity, and treat-
ment with KK-S6 further impaired the reporter activity (Fig. 4A).
Moreover, KK-S6 suppressed Bmal1::ELuc (emerald luciferase) ac-
tivity in WT mouse embryonic ﬁbroblast cells (MEFs), but its
repressive effect on RORE-mediated transcription was lost in MEFs
derived fromRev-erba knock-outmice (Fig. 4B). These data indicate
that KK-S6 may reinforce the transcriptional repression activity of
REV-ERBs. We further attempted to determine whether KK-S6
could modulate mRNA expression levels of two genes that act on
downstream of REV-ERBa and contain the RORE cis-element in
their promoter in HepG2 cells. Sequence analysis shows that like a
Bmal1 promoter, Plasminogen activator inhibitor-1 (Pai-1) [23]
promoter has two putative ROREs, whereas that of Citrate syn-
thase [24] has one. All three genes can be directly regulated by REV-
ERBa [25]. Treatment of KK-S6 repressed the transcription levels ofFig. 3. Inﬂuence of KK-S6 on endogenous circadian clockworks. (A) Changes in Bmal1mR
for 24 h. Heme (30 mM) and GSK4112 (15 mM) were used for comparison. (n ¼ 4e9). **p
treatment with heme (30 mM), lithium (10 mM), or KK-S6 (5 mM) for 24 h *p < 0.05 comp
expression of wtBmal1::Luc (C) and Per2::Luc (D) reporters. NIH3T3 cells harboring the ind
vehicle (0.05% DMSO) or KK-S6 (1.25, 2.5, or 5 mM).these genes as strongly as heme, the endogenous ligand, and
GSK4112, a REV-ERB agonist (Fig. 4C).
GSK4112, a synthetic agonist, inhibited the activity of a lucif-
erase reporter containing a GAL4 binding promoter (GAL4-UAS-
Luc) in the presence of a chimeric protein, in which the DNA-
binding domain (DBD) of GAL4 was fused to the ligand-binding
and transcriptional repression domains of REV-ERBa (GAL4-REV).
In contrast to GSK4112, KK-S6 did not affect the activity of GAL4-
UAS-Luc reporter (Fig. 4D). Therefore, KK-S6 does not seem to be
a classical REV-ERB agonist, suggesting a non-canonical or indirect
mechanism.
4. Discussion
The present study identiﬁes a novel compound that suppresses
Bmal1 gene expression, thereby attenuating the circadian rhyth-
micity of molecular clockworks. KK-S6 reduced both BMAL1 mRNA
and protein expression by a RORE-dependent mechanism and,
more importantly, impaired the amplitude of rhythmic E-box and
RORE-mediated transcription. The inhibitory effect of KK-S6 on
BMAL1 expression appears to involve enhanced transcriptional
repression by REV-ERBs, which are key negative regulators of
Bmal1 gene transcription. KK-S6 is, however, distinct from recently
identiﬁed endogenous and synthetic agonists of REV-ERBs in terms
of its mode of action as well as its structural features [14,16].
REV-ERBs play an important role in stabilizing the period of
circadian rhythms by controlling cyclic expression of BMAL1, an
indispensable transcription factor of circadian molecular clock-
work. In addition to circadian rhythmicities, recent studies
demonstrated that REV-ERBs are heavily involved in the regulation
of a wide range of physiological processes such as metabolic and
energy homeostasis, inﬂammation, cardiovascular function, and
neural function [16]. It was proposed that synthetic REV-ERBNA expression in HepG2 cells by treatment with vehicle (0.05% DMSO) or KK-S6 (5 mM)
< 0.01 compared to vehicle -treated group. (B) Alteration of BMAL1 protein levels by
ared to vehicle-treated group. (C and D) Dose-dependent effects of KK-S6 on cycling
icated luciferase reporter were synchronized with 1 mM DEX for 2 h then treated with
J. Lee et al. / Biochemical and Biophysical Research Communications 469 (2016) 580e586 585ligands may be beneﬁcial in treatment of metabolic diseases as well
as sleep disorders. Twometabolic genes acting downstream of REV-
ERBa were signiﬁcantly decreased by KK-S6 at the transcriptional
level in Fig. 4. In fact, Pai-1 plays a critical role in inﬂammation and
the ﬁbrinolytic system, whereas Citrate synthase, a citrate producer,
is heavily involved in lipogenesis and cholesterologenesis [23,24]. It
is thus worth noting that KK-S6 could control metabolic homeo-
stasis, as REV-ERBa is a link between the circadian timing system
and metabolism.
Furthermore, our previous study showed that modulating REV-
ERBa activity, particularly in the midbrain, had an impact on the
regulation of mood states [19]. It is reasonable that RORE-mediated
transcriptional repression of downstream genes, including Bmal1,
may underlie the effect of REV-ERBs on such a wide variety of
biological processes. In addition to REV-ERB agonists, KL001, a
recently developed small molecule CRY stabilizer, could reinforce
feedback inhibition of CRYs on the E-box-mediated transcriptional
activity of the CLOCK:BMAL1 heterodimer [17].
It should be noted that the mode of action and chemical struc-
ture of KK-S6 are distinct from previously reported synthetic REV-
ERB agonists, which act on the heme-binding site in the ligand-
binding domain [14,16]. Although KK-S6 enhanced REV-ERB func-
tion, and as a result repressed RORE-mediated transcriptional
activation, our mammalian one-hybrid assay based on a chimeric
REV-ERBa-LBD fused with the GAL4 DBD suggested that it may not
act on REV-ERBa LBD as shown in Fig. 4. Rather, KK-S6 may affectFig. 4. Effects of KK-S6 on REV-ERBa. (A) Enhanced REV-ERBa activity by treatment with
with vehicle (0.05% DMSO) or KK-S6 (10 mM). (n ¼ 6). **p < 0.01 compared to vehicle-trea
embryonic ﬁbroblast cells (MEFs) were obtained from crosses between Bmal1::ELuc/Rev-erb
to vehicle-treated group. (C) Effect of KK-S6 on mRNA expression of Pai-1 and Citrate syntha
KK-S6 (5 mM) for 24 h. Heme (30 mM) and GSK4112 (15 mM) were used for comparison. (n ¼ 4
ERBa-LBD harboring the GAL4-DBD (GAL4-REV). NIH3T3 cells were co-transfected with GAL
KK-S6 (10 mM). (n ¼ 6). *p < 0.05 compared to control group.the post-translational modiﬁcation of REV-ERBs, and thus modu-
late their activity and/or stability. One possibility is that REV-ERBs
can undergo ubiquitin-dependent proteasomal degradation by E3
ligases such as ARF-BP1 and PAM, which is phosphorylation state-
dependent by KK-S6. For example, GSK3b stabilizes REV-ERBa by
phosphorylation, thereby suppressing Bmal1 transcription;
whereas lithium, an inhibitor of GSK3b, can accelerate degradation
of the protein [26]. Notably, treatment with lithium increased the
period length of both Per2::Luc and Bmal1::Luc rhythms, but it
barely affected the amplitude of the Bmal1::Luc rhythm [27]. Since
KK-S6 mainly inﬂuenced the amplitude of both Per2::Luc and
Bmal1::Luc rhythms rather than the length, it is unclear whether
the mechanism of action of KK-S6 is related to GSK3b-mediated
phosphorylation of REV-ERBs. Another possibility involves a direct
allosteric effect of KK-S6 on REV-ERB function, which is a phe-
nomenon seen in various other members of the nuclear receptor
superfamilies [28]. REV-ERBs form complexes with co-repressors
such as NCoR and HDAC3, which suppress the transcription of
target genes upon activation by a ligand [9]. Therefore, it is also
plausible that the effect of KK-S6 is produced by an allosteric sta-
bilization of the binding of co-repressors and/or endogenous li-
gands to REV-ERBs.
In conclusion, we discovered a novel modulator of the
mammalian clock by conducting a cell-based screening of our in-
house chemical library and characterized a mechanism of action
that exhibited capacity to modulate RORE-mediated activity.KK-S6. NIH3T3 cells were transfected with wtBmal1::Luc and/or Rev-erba and treated
ted group. (B) Effect of KK-S6 on REV-ERBa. Wild-type or Rev-erba knock-out mouse
aþ/- and Rev-erbaþ/- mice and treated with KK-S6 (5 mM). (n ¼ 3). **p < 0.01 compared
se genes affected by REV-ERBa. HepG2 cells were treated with vehicle (0.05% DMSO) or
e9). **p < 0.01 compared to vehicle-treated group. (D) Effect of KK-S6 on chimeric REV-
4-responsive luciferase reporter with GAL4-REV then treated with GSK4112 (15 mM) or
J. Lee et al. / Biochemical and Biophysical Research Communications 469 (2016) 580e586586Evidence obtained in the present study strongly suggests KK-S6 has
a distinct mode of action, presumably involving post-translational
and/or allosteric mechanisms. As reinforcing REV-ERB activity
and impairing the transactivation by the CLOCK:BMAL1 hetero-
dimer have been proposed as new strategies to treat circadian
rhythm-related diseases, including metabolic disorders, KK-S6 may
provide a tool to study the regulation of REV-ERB-dependent
physiology and aid development of molecular clockwork-based
therapeutics.
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